I think that probably the predominant factor that will drive changes in life expectancy over the next 5 to 10 years will be better treatment of obesity with GLP-1 receptor agonists and related agents. Given the potentially huge health benefits of these diabetes and weight loss drugs, should insurers and government programs such as Medicaid widely cover their use
These play a significant role in malodorous gas production, she said
This triple mechanism is intended to reduce appetite, improve glucose regulation, and increase energy expenditure
Yet Lillys sales growth suggests a quickly closing gap, with Mounjaros 71% quarterly growth and Zepbounds 140% quarterly increase
GLP-1RA drugs activate receptors in the brain that cause these side effects, but over time the body and mind adapt and the issues often diminish
You are pregnant, breastfeeding, or trying to conceive